ProCE Banner Activity

Immunotherapy in Lung Cancer: The Role of IO Biomarkers in Treatment Choice

Slideset Download
Download this slideset from Jamie E. Chaft, MD and Kristin Higgins, MD to review key data on the current use of IO biomarker testing, immunotherapy, and CRT for patients with lung cancer.

Released: October 23, 2020

Expiration: October 22, 2021

Share

Faculty

Jamie E. Chaft

Jamie E. Chaft, MD

Associate Attending Physician
Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York

Kristin Higgins

Kristin Higgins, MD

Medical Director
Associate Professor

Department of Radiation Oncology
Emory University
Atlanta, Georgia

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Jamie E. Chaft, MD

Associate Attending Physician
Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York

Kristin Higgins, MD

Medical Director
Associate Professor

Department of Radiation Oncology
Emory University
Atlanta, Georgia